ACM
TVGN icon

Atalaya Capital Management’s Tevogen Inc. Common Stock TVGN Stock Holding History

Atalaya Capital Management’s Portfolio TVGN Stock Details TVGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,000
Closed -$4.13M – 228
2022
Q4 		$4.13M Hold
8,000
– – 0.74% 35
2022
Q3 		$4.06M Buy
+8,000
New +$4.04M 0.55% 51

Other funds holding TVGN

CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atalaya Capital Management's TVGN Position: Q1 2023 in Review

Atalaya Capital Management sold out of Tevogen Inc. Common Stock (TVGN) in Q1 2023, closing a stake of 8,000 shares — an estimated $4.13M sold.

Atalaya Capital Management first reported a position in TVGN in Q3 2022 and held it in 2 quarters. The position peaked at $4.13M in Q4 2022. 4 funds tracked by Wall St. Rank hold TVGN as of Q1 2023.

  • Atalaya Capital Management reported no remaining Tevogen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Atalaya Capital Management sold 8,000 Tevogen Inc. Common Stock shares in Q1 2023, an estimated $4.13M.
  • Atalaya Capital Management first reported a position in Tevogen Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Atalaya Capital Management's Tevogen Inc. Common Stock position peaked at $4.13M in Q4 2022.
  • 4 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q1 2023.

Based on Atalaya Capital Management's 13F filing for Q1 2023, filed 11 May 2023.